Brief: SkinBioTherapeutics H1 EPS GBP -0.007
22/03/2024 07:23
Mar 22 (Reuters) - SkinBioTherapeutics H1 EPS GBP -0.007
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company